"dipivoxil" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "di",
        "3": "pivoxil"
      },
      "expansion": "di- + pivoxil",
      "name": "prefix"
    }
  ],
  "etymology_text": "From di- + pivoxil.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "dipivoxil (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with di-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "derived": [
        {
          "word": "adefovir dipivoxil"
        }
      ],
      "examples": [
        {
          "ref": "2009 October 11, Amy Zipkin, “On the Discovery Trail”, in New York Times:",
          "text": "I joined Gilead Sciences in 1990, and by 1999 we were in the final stage of about five or six years of work in creating the drug adefovir dipivoxil to treat H.I.V. The drug wasn’t approved by the F.D.A. for H.I.V. because the data showed evidence of kidney toxicity.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Applied to a diester pivoxil prodrug of adefovir."
      ],
      "id": "en-dipivoxil-en-adj-wonPCJje",
      "links": [
        [
          "diester",
          "diester#English"
        ],
        [
          "pivoxil",
          "pivoxil#English"
        ],
        [
          "prodrug",
          "prodrug#English"
        ],
        [
          "adefovir",
          "adefovir#English"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "dipivoxil"
}

{
  "derived": [
    {
      "word": "adefovir dipivoxil"
    }
  ],
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "di",
        "3": "pivoxil"
      },
      "expansion": "di- + pivoxil",
      "name": "prefix"
    }
  ],
  "etymology_text": "From di- + pivoxil.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "dipivoxil (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with di-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2009 October 11, Amy Zipkin, “On the Discovery Trail”, in New York Times:",
          "text": "I joined Gilead Sciences in 1990, and by 1999 we were in the final stage of about five or six years of work in creating the drug adefovir dipivoxil to treat H.I.V. The drug wasn’t approved by the F.D.A. for H.I.V. because the data showed evidence of kidney toxicity.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Applied to a diester pivoxil prodrug of adefovir."
      ],
      "links": [
        [
          "diester",
          "diester#English"
        ],
        [
          "pivoxil",
          "pivoxil#English"
        ],
        [
          "prodrug",
          "prodrug#English"
        ],
        [
          "adefovir",
          "adefovir#English"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "dipivoxil"
}